Cargando…
Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications
Diabetes is a leading cause of cardiovascular morbidity and mortality. Despite numerous treatments for cardiovascular disease (CVD), for patients with diabetes, these therapies provide less benefit for protection from CVD. These considerations spur the concept that diabetes-specific, disease-modifyi...
Autores principales: | Jannapureddy, Sravya, Sharma, Mira, Yepuri, Gautham, Schmidt, Ann Marie, Ramasamy, Ravichandran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992003/ https://www.ncbi.nlm.nih.gov/pubmed/33776930 http://dx.doi.org/10.3389/fendo.2021.636267 |
Ejemplares similares
-
Aldose Reductase Drives Hyperacetylation of Egr-1 in Hyperglycemia and Consequent Upregulation of Proinflammatory and Prothrombotic Signals
por: Vedantham, Srinivasan, et al.
Publicado: (2014) -
Aldose Reductase B1 in Pig Sperm Is Related to Their Function and Fertilizing Ability
por: Mateo-Otero, Yentel, et al.
Publicado: (2022) -
Macrophage-adipocyte communication and cardiac remodeling
por: Yepuri, Gautham, et al.
Publicado: (2021) -
Aldose reductase modulates acute activation of mesenchymal markers via the β-catenin pathway during cardiac ischemia-reperfusion
por: Thiagarajan, Devi, et al.
Publicado: (2017) -
Cardiomyocyte Aldose Reductase Causes Heart Failure and Impairs Recovery from Ischemia
por: Son, Ni-Huiping, et al.
Publicado: (2012)